A Comparative Study on the Hormonal Responses to Insulin‐induced Hypoglycaemia Using Semisynthetic Human Insulin and Pork Insulin in Patients with Type 1 Diabetes Mellitus

In order to enlighten the controversy on whether human and pork insulin result in different hormonal responses to insulin‐induced hypoglycaemia, eight C‐peptide negative, diabetic patients without measurable circulating insulin‐binding antibodies were exposed to insulin‐induced hypoglycaemia in random order with highly purified pork insulin (Actrapid) and semisynthetic human insulin (Actrapid Human). Hypoglycaemia was provoked by a constant rate IV infusion of insulin (0.034 U kg‐1 h‐1) for 3 h after which the blood glucose recovery was assessed for an additional period of 60 min. Both insulin preparations gave close to identical responses for glucose, glucagon, growth hormone, adrenaline, and somatostatin. The circulating noradrenaline levels were higher during the infusion of pork insulin which also yielded a more prominent response of pancreatic polypeptide and, after cessation of the insulin infusion, plasma cortisol was also higher following pork insulin. It is concluded that human and pork insulin induce close to identical responses of the important counter‐regulatory hormones during hypoglycaemia in Type 1 diabetic patients.

[1]  N. Christensen,et al.  The acute effect of insulin on heart rate, blood pressure, plasma noradrenaline and urinary albumin excretion , 1980, Diabetologia.

[2]  R. Heine,et al.  RESPONSES TO HUMAN AND PORCINE INSULIN IN HEALTHY SUBJECTS , 1989, The Lancet.

[3]  E. Jaeggi,et al.  WARNING SYMPTOMS OF HYPOGLYCAEMIA DURING TREATMENT WITH HUMAN AND PORCINE INSULIN IN DIABETES MELLITUS , 1989, The Lancet.

[4]  B. Frier,et al.  Responses to acute insulin-induced hypoglycaemia in diabetic patients: a comparison of short-acting human and porcine insulins. , 1988, Diabetes research.

[5]  D. Owens,et al.  Hormonal counterregulatory responses to human (semi-synthetic and recombinant DNA) and porcine insulin induced hypoglycaemia. , 1988, Diabetes research.

[6]  A. Teuscher,et al.  HYPOGLYCAEMIA UNAWARENESS IN DIABETICS TRANSFERRED FROM BEEF/ PORCINE INSULIN TO HUMAN INSULIN , 1987, The Lancet.

[7]  J. Jeppsson,et al.  Measurement of hemoglobin A1c by a new liquid-chromatographic assay: methodology, clinical utility, and relation to glucose tolerance evaluated. , 1986, Clinical chemistry.

[8]  J. Tooke,et al.  The effects of intravenous insulin infusion on skin microcirculatory flow in Type 1 diabetes. , 1985, International journal of microcirculation, clinical and experimental.

[9]  P. Scriba,et al.  Comparative study of hormonal counter-regulation during GCIIS-guided insulin hypoglycemia tests using human insulin (recombinant DNA) and pork insulin. , 1985, Diabetes research.

[10]  Peggy Wu,et al.  STUDIES ON THE MECHANISMS OF SOMATOSTATIN RELEASE AFTER INSULIN INDUCED HYPOGLYCAEMIA IN MAN , 1984, Clinical endocrinology.

[11]  T. Schwartz,et al.  Pancreatic polypeptide: a hormone under vagal control. , 1983, Gastroenterology.

[12]  W. Waldhäusl,et al.  Insulin pharmacokinetics following continuous infusion and bolus injection of regular porcine and human insulin in healthy man. , 1983, Metabolism: clinical and experimental.

[13]  P. Sönksen,et al.  Porcine and human insulin (Novo): a comparison of their metabolism and hypoglycemic activity in normal man. , 1983, Diabetes care.

[14]  I. Björkhem,et al.  Assay of cortisol with a radioimmunoassay method calibrated by isotope dilution-mass spectrometry. A Nordic collaborative study. , 1983, Scandinavian journal of clinical and laboratory investigation.

[15]  L. Kerp,et al.  Less Pronounced Changes in Serum Potassium and Epinephrine During Hypoglycemia Induced by Human Insulin (recombinant DNA) , 1982, Diabetes Care.

[16]  F. Enzmann,et al.  Comparative Studies on Intermediary Metabolism and Hormonal Counterregulation Following Human Insulin (recombinant DNA) and Purified Pork Insulin in Man , 1982, Diabetes Care.

[17]  F. Enzmann,et al.  Different Counterregulatory Responses to Human Insulin (recombinant DNA) and Purified Pork Insulin , 1982, Diabetes Care.

[18]  T. M. Hayes,et al.  Human insulin: study of safety and efficacy in man. , 1981, British medical journal.

[19]  H. Velcovsky,et al.  Biologic and Immunologic in Vivo and In Vitro Studies with Biosynthetic Human Insulin , 1981, Diabetes Care.

[20]  K. Alberti,et al.  A Comparative Study of the Activity of Biosynthetic Human Insulin and Pork Insulin Using the Glucose Clamp Technique in Normal Subjects , 1981, Diabetes Care.

[21]  S. Raptis,et al.  Biologic Activities of Biosynthetic Human Insulin in Healthy Volunteers and Insulin-dependent Diabetic Patients Monitored by the Artificial Endocrine Pancreas , 1981, Diabetes Care.

[22]  R. Bilous,et al.  HUMAN INSULIN PRODUCED BY RECOMBINANT DNA TECHNOLOGY: SAFETY AND HYPOGLYCÆMIC POTENCY IN HEALTHY MEN , 1980, The Lancet.

[23]  B. Hamberger,et al.  A sensitive method for the determination of plasma catecholamines using liquid chromatography with electrochemical detection. , 1978, Life sciences.

[24]  A. Schally,et al.  Radioimmunoassay of somatostatin. , 1978, Metabolism: clinical and experimental.

[25]  P. Watkins,et al.  CARDIORESPIRATORY ARREST AND DIABETIC AUTONOMIC NEUROPATHY , 1978, The Lancet.

[26]  J. A. Hedo,et al.  Control of pancreatic polypeptide secretion by glucose in man. , 1978, The Journal of clinical endocrinology and metabolism.

[27]  K. Mashimo,et al.  A Simple Method for the Determination of Serum Free Insulin Levels in Insulin-treated Patients , 1973, Diabetes.

[28]  E. Cerasi,et al.  Determination of human growth hormone (HGH) in plasma by a double antibody radioimmunoassay. , 1966, Acta endocrinologica.

[29]  N. A. Coulter,et al.  Respiratory sinus arrhythmia: a frequency dependent phenomenon , 1964 .